Home > > > > > Report Detail

Global Pulmonary Arterial Hypertension (PAH) Market Insights: Impact of COVID-19 and Future Expectations to 2028

Publisher Name :
Date: 30-May-2023
No. of pages: 118

The Pulmonary Arterial Hypertension (PAH) market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.

This report elaborates the market size, market characteristics, and market growth of the Pulmonary Arterial Hypertension (PAH) industry, and breaks down according to the type, application, and consumption area of Pulmonary Arterial Hypertension (PAH). The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.

In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Pulmonary Arterial Hypertension (PAH) in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.

Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.

Key players in the global Pulmonary Arterial Hypertension (PAH) market covered in Chapter 11:

GlaxoSmithKline

Pfizer

Gilead Sciences

United Therapeutics

Bayer

Actelion

Arena

In Chapter 3, on the basis of types, the Pulmonary Arterial Hypertension (PAH) market from 2018 to 2028 is primarily split into:

Prostacyclin and Prostacyclin Analogs

SGC Stimulators

ERA

PDE-5

In Chapter 4, on the basis of applications, the Pulmonary Arterial Hypertension (PAH) market from 2018 to 2028 covers:

Hospital

Clinic

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:

North America (Covered in Chapter 6)

United States

Canada

Mexico

Europe (Covered in Chapter 7)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8)

China

Japan

South Korea

Australia

India

Middle East and Africa (Covered in Chapter 9)

Saudi Arabia

UAE

Egypt

South Africa

South America (Covered in Chapter 10)

Brazil

Argentina

Columbia

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global Pulmonary Arterial Hypertension (PAH) Market Insights: Impact of COVID-19 and Future Expectations to 2028

Table of Content

1 Report Overview
1.1 Research Objectives
1.2 Study Scope
1.3 Key Market Segments
1.4 Market Investment Scenario Strategic

2 Industry Insights
2.1 Industry Ecosystem Analysis
2.1.1 Industry Chain Analysis
2.1.2 Distribution Channel Analysis
2.2 Market Trend Analysis
2.2.1 Growth Drivers
2.2.2 Industry Constraints and Challenges
2.3 Industry Trends Under COVID-19
2.3.1 Risk Assessment on COVID-19
2.3.2 Assessment of the Overall Impact of COVID-19 on the Industry
2.3.3 Pre COVID-19 and Post COVID-19 Market Scenario
2.4 Industry Innovation Prospect Analysis
2.5 The Impact of Covid-19 From the Perspective of Industry Chain

3 Global Pulmonary Arterial Hypertension (PAH) Market, By Product Type
3.1 Global Pulmonary Arterial Hypertension (PAH) Sales, Revenue and Market Share by Types (2018-2023)
3.1.1 Global Pulmonary Arterial Hypertension (PAH) Sales and Market Share by Types (2018-2023)
3.1.2 Global Pulmonary Arterial Hypertension (PAH) Revenue and Market Share by Types (2018-2023)
3.1.3 Global Pulmonary Arterial Hypertension (PAH) Price by Types (2018-2023)
3.2 Key Trends by Types
3.3 Global Pulmonary Arterial Hypertension (PAH) Sales, Price and Growth Rate of Prostacyclin and Prostacyclin Analogs (2018-2023)
3.4 Global Pulmonary Arterial Hypertension (PAH) Sales, Price and Growth Rate of SGC Stimulators (2018-2023)
3.5 Global Pulmonary Arterial Hypertension (PAH) Sales, Price and Growth Rate of ERA (2018-2023)
3.6 Global Pulmonary Arterial Hypertension (PAH) Sales, Price and Growth Rate of PDE-5 (2018-2023)

4 Global Pulmonary Arterial Hypertension (PAH) Market, By Applications
4.1 Global Pulmonary Arterial Hypertension (PAH) Consumption, Revenue and Market Share by Applications (2018-2023)
4.1.1 Global Pulmonary Arterial Hypertension (PAH) Consumption and Market Share by Applications (2018-2023)
4.1.2 Global Pulmonary Arterial Hypertension (PAH) Revenue and Market Share by Applications (2018-2023)
4.2 Hospital
4.3 Clinic

5 Global Pulmonary Arterial Hypertension (PAH) Market, By Regions
5.1 Global Pulmonary Arterial Hypertension (PAH) Market Sales and Market Share by Regions
5.1.1 Global Pulmonary Arterial Hypertension (PAH) Sales by Regions (2018-2023)
5.1.2 Global Pulmonary Arterial Hypertension (PAH) Sales Market Share by Regions (2018-2023)
5.2 Global Pulmonary Arterial Hypertension (PAH) Market Revenue and Market Share by Regions
5.2.1 Global Pulmonary Arterial Hypertension (PAH) Revenue by Regions (2018-2023)
5.2.2 Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Regions (2018-2023)
5.3 Key Trends by Regions
5.3.1 Emerging Market Analysis

6 North America Pulmonary Arterial Hypertension (PAH) Market Analysis
6.1 North America Pulmonary Arterial Hypertension (PAH) Market Size
6.1.1 North America Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
6.1.2 North America Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
6.2 U.S. Pulmonary Arterial Hypertension (PAH) Market Size
6.3 Canada Pulmonary Arterial Hypertension (PAH) Market Size
6.4 Mexico Pulmonary Arterial Hypertension (PAH) Market Size
6.5 Key Macroeconomic Indicators
6.6 The Influence of COVID-19 on North America Market

7 Europe Pulmonary Arterial Hypertension (PAH) Market Analysis
7.1 Europe Pulmonary Arterial Hypertension (PAH) Market Size
7.1.1 Europe Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
7.1.2 Europe Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
7.2 Germany Pulmonary Arterial Hypertension (PAH) Market Size
7.3 United Kingdom Pulmonary Arterial Hypertension (PAH) Market Size
7.4 France Pulmonary Arterial Hypertension (PAH) Market Size
7.5 Italy Pulmonary Arterial Hypertension (PAH) Market Size
7.6 Spain Pulmonary Arterial Hypertension (PAH) Market Size
7.7 Russia Pulmonary Arterial Hypertension (PAH) Market Size
7.8 Key Macroeconomic Indicators
7.9 The Influence of COVID-19 on Europe Market

8 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Analysis
8.1 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Size
8.1.1 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
8.1.2 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
8.2 China Pulmonary Arterial Hypertension (PAH) Market Size
8.3 Japan Pulmonary Arterial Hypertension (PAH) Market Size
8.4 South Korea Pulmonary Arterial Hypertension (PAH) Market Size
8.5 Australia Pulmonary Arterial Hypertension (PAH) Market Size
8.6 India Pulmonary Arterial Hypertension (PAH) Market Size
8.7 Key Macroeconomic Indicators
8.8 The Influence of COVID-19 on Asia Pacific Market

9 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Market Analysis
9.1 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Market Size
9.1.1 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
9.1.2 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
9.2 Saudi Arabia Pulmonary Arterial Hypertension (PAH) Market Size
9.3 UAE Pulmonary Arterial Hypertension (PAH) Market Size
9.4 Egypt Pulmonary Arterial Hypertension (PAH) Market Size
9.5 South Africa Pulmonary Arterial Hypertension (PAH) Market Size
9.6 Key Macroeconomic Indicators
9.7 The Influence of COVID-19 on Middle East and Africa Market

10 South America Pulmonary Arterial Hypertension (PAH) Market Analysis
10.1 South America Pulmonary Arterial Hypertension (PAH) Market Size
10.1.1 South America Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
10.1.2 South America Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
10.2 Brazil Pulmonary Arterial Hypertension (PAH) Market Size
10.3 Argentina Pulmonary Arterial Hypertension (PAH) Market Size
10.4 Columbia Pulmonary Arterial Hypertension (PAH) Market Size
10.5 Key Macroeconomic Indicators
10.6 The Influence of COVID-19 on South America Market

11 Competition Landscape and Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Basic Information
11.1.2 GlaxoSmithKline Product Profiles, Application and Specification
11.1.3 GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Market Performance (2018-2023)
11.2 Pfizer
11.2.1 Pfizer Basic Information
11.2.2 Pfizer Product Profiles, Application and Specification
11.2.3 Pfizer Pulmonary Arterial Hypertension (PAH) Market Performance (2018-2023)
11.3 Gilead Sciences
11.3.1 Gilead Sciences Basic Information
11.3.2 Gilead Sciences Product Profiles, Application and Specification
11.3.3 Gilead Sciences Pulmonary Arterial Hypertension (PAH) Market Performance (2018-2023)
11.4 United Therapeutics
11.4.1 United Therapeutics Basic Information
11.4.2 United Therapeutics Product Profiles, Application and Specification
11.4.3 United Therapeutics Pulmonary Arterial Hypertension (PAH) Market Performance (2018-2023)
11.5 Bayer
11.5.1 Bayer Basic Information
11.5.2 Bayer Product Profiles, Application and Specification
11.5.3 Bayer Pulmonary Arterial Hypertension (PAH) Market Performance (2018-2023)
11.6 Actelion
11.6.1 Actelion Basic Information
11.6.2 Actelion Product Profiles, Application and Specification
11.6.3 Actelion Pulmonary Arterial Hypertension (PAH) Market Performance (2018-2023)
11.7 Arena
11.7.1 Arena Basic Information
11.7.2 Arena Product Profiles, Application and Specification
11.7.3 Arena Pulmonary Arterial Hypertension (PAH) Market Performance (2018-2023)

12 Global Pulmonary Arterial Hypertension (PAH) Market Forecast, By Type and Applications
12.1 Global Pulmonary Arterial Hypertension (PAH) Market Forecast by Types (2023-2028)
12.1.1 Global Pulmonary Arterial Hypertension (PAH) Market Forecast Sales and Market Share by Types (2023-2028)
12.1.2 Global Pulmonary Arterial Hypertension (PAH) Market Forecast Revenue and Market Share by Types (2023-2028)
12.2 Global Pulmonary Arterial Hypertension (PAH) Market Forecast by Applications (2023-2028)
12.2.1 Global Pulmonary Arterial Hypertension (PAH) Market Forecast Consumption and Market Share by Applications (2023-2028)
12.2.2 Global Pulmonary Arterial Hypertension (PAH) Market Forecast Revenue and Market Share by Applications (2023-2028)

13 Global Pulmonary Arterial Hypertension (PAH) Market Forecast, By Regions
13.1 Global Pulmonary Arterial Hypertension (PAH) Market Forecast Sales and Market Share by Regions (2023-2028)
13.2 Global Pulmonary Arterial Hypertension (PAH) Market Forecast Revenue and Market Share by Regions (2023-2028)
13.3 North America Pulmonary Arterial Hypertension (PAH) Market Forecast (2023-2028)
13.4 Europe Pulmonary Arterial Hypertension (PAH) Market Forecast (2023-2028)
13.5 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Forecast (2023-2028)
13.6 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Market Forecast (2023-2028)
13.7 South America Pulmonary Arterial Hypertension (PAH) Market Forecast (2023-2028)

14 Appendix
14.1 Methodology
14.2 Research Data Source
14.2.1 Secondary Data
14.2.2 Primary Data
14.2.3 Market Size Estimation
14.2.4 Legal Disclaimer

List of Tables and Figures

Table Pulmonary Arterial Hypertension (PAH) Key Market Segments
Figure Global Pulmonary Arterial Hypertension (PAH) Market Size and Growth Rate 2018-2028
Figure Channel Status of Pulmonary Arterial Hypertension (PAH)
Table Market Driving Factors of Pulmonary Arterial Hypertension (PAH)
Table Market Industry Constraints and Challenges of Pulmonary Arterial Hypertension (PAH)
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Table Global Pulmonary Arterial Hypertension (PAH) Sales by Types (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Sales Share by Types (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Revenue ($) by Types (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Revenue Share by Types (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Price by Types (2018-2023)
Figure Global Prostacyclin and Prostacyclin Analogs Sales and Growth Rate (2018-2023)
Figure Global Prostacyclin and Prostacyclin Analogs Price (2018-2023)
Figure Global SGC Stimulators Sales and Growth Rate (2018-2023)
Figure Global SGC Stimulators Price (2018-2023)
Figure Global ERA Sales and Growth Rate (2018-2023)
Figure Global ERA Price (2018-2023)
Figure Global PDE-5 Sales and Growth Rate (2018-2023)
Figure Global PDE-5 Price (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Consumption by Applications (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Consumption Share by Applications (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Revenue ($) by Applications (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Revenue Share by Applications (2018-2023)
Figure Global Hospital Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Clinic Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Pulmonary Arterial Hypertension (PAH) Sales and Growth Rate (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Sales by Regions (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Sales Market Share by Regions (2018-2023)
Figure Global Pulmonary Arterial Hypertension (PAH) Sales Market Share by Regions in 2022
Figure Global Pulmonary Arterial Hypertension (PAH) Revenue and Growth Rate (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Revenue by Regions (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Regions (2018-2023)
Figure Global Pulmonary Arterial Hypertension (PAH) Revenue Market Share by Regions in 2022
Figure North America Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Table North America Pulmonary Arterial Hypertension (PAH) Sales by Countries (2018-2023)
Figure North America Pulmonary Arterial Hypertension (PAH) Market Revenue ($) and Growth Rate (2018-2023)
Table North America Pulmonary Arterial Hypertension (PAH) Revenue ($) by Countries (2018-2023)
Figure U.S. Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure U.S. Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure Canada Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure Canada Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure Mexico Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure Mexico Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure North America COVID-19 Status
Figure Europe Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Table Europe Pulmonary Arterial Hypertension (PAH) Sales by Countries (2018-2023)
Figure Europe Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Table Europe Pulmonary Arterial Hypertension (PAH) Revenue by Countries (2018-2023)
Figure Germany Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure Germany Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure United Kingdom Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure United Kingdom Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure France Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure France Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure Italy Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure Italy Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure Spain Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure Spain Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure Russia Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure Russia Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure Europe COVID-19 Status
Figure Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Table Asia-Pacific Pulmonary Arterial Hypertension (PAH) Sales by Countries (2018-2023)
Figure Asia-Pacific Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Table Asia-Pacific Pulmonary Arterial Hypertension (PAH) Revenue by Countries (2018-2023)
Figure China Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure China Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure Japan Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure Japan Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure South Korea Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure South Korea Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure Australia Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure Australia Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure India Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure India Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Table Middle East and Africa Pulmonary Arterial Hypertension (PAH) Sales by Countries (2018-2023)
Figure Middle East and Africa Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Table Middle East and Africa Pulmonary Arterial Hypertension (PAH) Revenue by Countries (2018-2023)
Figure Saudi Arabia Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure Saudi Arabia Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure UAE Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure UAE Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure Egypt Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure Egypt Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure South Africa Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure South Africa Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure South America Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Table South America Pulmonary Arterial Hypertension (PAH) Sales by Countries (2018-2023)
Figure South America Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Table South America Pulmonary Arterial Hypertension (PAH) Revenue by Countries (2018-2023)
Figure Brazil Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure Brazil Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure Argentina Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure Argentina Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Figure Columbia Pulmonary Arterial Hypertension (PAH) Market Sales and Growth Rate (2018-2023)
Figure Columbia Pulmonary Arterial Hypertension (PAH) Market Revenue and Growth Rate (2018-2023)
Table GlaxoSmithKline Company Profile
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2018-2023
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Value ($) Market Share 2018-2023
Table Pfizer Company Profile
Table Pfizer Production, Value, Price, Gross Margin 2018-2023
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2018-2023
Table Gilead Sciences Company Profile
Table Gilead Sciences Production, Value, Price, Gross Margin 2018-2023
Figure Gilead Sciences Production and Growth Rate
Figure Gilead Sciences Value ($) Market Share 2018-2023
Table United Therapeutics Company Profile
Table United Therapeutics Production, Value, Price, Gross Margin 2018-2023
Figure United Therapeutics Production and Growth Rate
Figure United Therapeutics Value ($) Market Share 2018-2023
Table Bayer Company Profile
Table Bayer Production, Value, Price, Gross Margin 2018-2023
Figure Bayer Production and Growth Rate
Figure Bayer Value ($) Market Share 2018-2023
Table Actelion Company Profile
Table Actelion Production, Value, Price, Gross Margin 2018-2023
Figure Actelion Production and Growth Rate
Figure Actelion Value ($) Market Share 2018-2023
Table Arena Company Profile
Table Arena Production, Value, Price, Gross Margin 2018-2023
Figure Arena Production and Growth Rate
Figure Arena Value ($) Market Share 2018-2023
Table Global Pulmonary Arterial Hypertension (PAH) Market Forecast Sales by Types (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Market Forecast Sales Share by Types (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Market Forecast Revenue ($) by Types (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Market Forecast Revenue Share by Types (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Market Forecast Consumption by Applications (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Market Forecast Consumption Share by Applications (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Market Forecast Revenue ($) by Applications (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Market Forecast Revenue Share by Applications (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Market Forecast Sales by Regions (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Market Forecast Sales Share by Regions (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Market Forecast Revenue ($) by Regions (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Market Forecast Revenue Share by Regions (2023-2028)
Figure North America Market Sales and Growth Rate Forecast (2023-2028)
Figure North America Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Europe Market Sales and Growth Rate Forecast (2023-2028)
Figure Europe Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Sales and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Sales and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure South America Market Sales and Growth Rate Forecast (2023-2028)
Figure South America Market Revenue ($) and Growth Rate Forecast (2023-2028)
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs